GlassScriptPhysician profile
Randall Colby Nelson
NPI 1790138782
$1,749.53
in general payments reported to CMS, 2019-2025
22 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $580 · 2023: $456 · 2024: $339 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $339.00 | 2021-2023 | Nuplazid |
| Novo Nordisk INC | $268.03 | 2021-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $254.95 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.70 | 2021-2025 | Jardiance |
| Abbvie INC. | $101.36 | 2022-2024 | |
| Neurocrine Biosciences, INC. | $96.55 | 2022 | |
| Novartis Pharmaceuticals Corporation | $81.32 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.28 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $59.01 | 2023-2024 | Caplyta |
| Mylan Specialty L.P. | $49.99 | 2023 | Yupelri |
| Braeburn INC. | $49.60 | 2024 | Brixadi |
| Pfizer INC. | $47.84 | 2021-2022 | |
| Exact Sciences Corporation | $36.09 | 2025 | The Cologuard Plus Collection Kit |
| Antares Pharma, INC. | $29.45 | 2022 | |
| Alkermes, INC. | $28.38 | 2023 | Vivitrol |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $25.90 | 2022 | |
| Philips North America LLC | $21.36 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Lundbeck LLC | $19.74 | 2024 | Rexulti |
| Xeris Pharmaceuticals, INC. | $18.90 | 2022 | |
| Glaxosmithkline, LLC. | $18.72 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.83 | 2021 | |
| Dexcom, INC. | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.